Keith Loria

“[The ability of] remote patient monitoring to provide targeted clinical information to physicians and elevate critical information for review and earlier intervention is enhancing patient communication and care delivery,” said Jim Brown, MD.

Telemedicine risks can be managed by staying informed and educated.

“Physicians should take medical board complaints far more seriously than a medical malpractice complaint,” said attorney Alex Keoskey.

“One has to be very careful about purchasing any kind of technology — especially ones that the patient will pay cash out of their pocket for,” said urologist Clifford Gluck, MD. “That’s why it’s important to get the experience of others who have used the technology and to look at the literature to see what there is in terms of scientific evidence.”

Private equity firms’ acquisition of physician practices has escalated in recent years, and urology practices are currently garnering great interest due to an increased demand for services from an aging population and a low supply of urologists.

Having four generations of physicians working in the same practice is both a blessing and a significant source of complications, said Haydn Shaw, CSP, at the LUGPA annual meeting in Chicago.

Cass Schaedig, vice president of provider analytics, ION Solutions for AmerisourceBergen, talks with Urology Times about the value of benchmarking in patient care, practice management, and health policy.

Among the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.

The update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.

Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.

A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.

A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.

Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.

Overweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.

Researchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.

“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.

A new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing.

An examination of data involving more than 63,000 PSA tests ordered by primary care physicians reveals some surprising findings.

A recent study shows children born to high-status parents have a higher incidence rate of developing prostate and other cancers in later life.

A team from Roswell Park Cancer Institute has developed and validated a quality assessment tool based on prospectively collected data on robot-assisted cystectomy.

Results from a recent prospective trial suggest that active surveillance may be suitable for some patients with advanced renal cell carcinoma.